SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001628280-22-020111
Filing Date
2022-08-02
Accepted
2022-08-02 08:50:55
Documents
67
Period of Report
2022-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q espr-20220630.htm   iXBRL 10-Q 1310959
2 EX-31.1 espr-ex311x06302022.htm EX-31.1 11115
3 EX-31.2 espr-ex312x06302022.htm EX-31.2 11165
4 EX-32.1 espr-ex321x06302022.htm EX-32.1 6263
  Complete submission text file 0001628280-22-020111.txt   6689697

Data Files

Seq Description Document Type Size
5 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT espr-20220630.xsd EX-101.SCH 51453
6 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT espr-20220630_cal.xml EX-101.CAL 51642
7 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT espr-20220630_def.xml EX-101.DEF 266378
8 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT espr-20220630_lab.xml EX-101.LAB 631643
9 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT espr-20220630_pre.xml EX-101.PRE 411204
61 EXTRACTED XBRL INSTANCE DOCUMENT espr-20220630_htm.xml XML 1026814
Mailing Address 3891 RANCHERO DRIVE, SUITE 150 ANN ARBOR MI 48108
Business Address 3891 RANCHERO DRIVE, SUITE 150 ANN ARBOR MI 48108 734-887-3903
Esperion Therapeutics, Inc. (Filer) CIK: 0001434868 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-35986 | Film No.: 221126997
SIC: 2834 Pharmaceutical Preparations